# Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma

> **NCT03496844** · NA · COMPLETED · sponsor: **University of Arizona** · enrollment: 15 (actual)

## Conditions studied

- Prostate Adenocarcinoma

## Interventions

- **DIAGNOSTIC_TEST:** F-18 fluciclovine-PET/CT scan

## Key facts

- **NCT ID:** NCT03496844
- **Lead sponsor:** University of Arizona
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-04-15
- **Primary completion:** 2021-04-27
- **Final completion:** 2021-04-27
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2022-08-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03496844

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03496844, "Fluciclovine-PET/CT for Bone Metastases From Prostate Adenocarcinoma". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03496844. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*